Medtronic plc Increase (Decrease) in Accounts Payable and Accrued Liabilities
Medtronic plc (MDT) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$531.00 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-09-03
- Medtronic plc increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-07-31 was -$531.00M.
- Medtronic plc increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-04-24 was $123.00M, a 66.39% decline year-over-year.
- Medtronic plc increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-01-23 was $703.00M, a 27.82% increase year-over-year.
- Medtronic plc increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-10-24 was -$182.00M.
- Medtronic plc increase (decrease) in accounts payable and accrued liabilities for fiscal 2026 was $46.00M, a 77.99% decline from fiscal 2025.
- Medtronic plc increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $209.00M, a 46.55% decline from fiscal 2024.
- Medtronic plc increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $391.00M, a 43.82% decline from fiscal 2023.
- Medtronic plc increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $696.00M, a 226.76% increase from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 7 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | -$531.00M 10-Q · filed 2026-09-03 | -$408.00M derived: sum of 2 quarters · filed 2026-09-03 | $295.00M derived: sum of 3 quarters · filed 2026-09-03 | $113.00M derived: sum of 4 quarters · filed 2026-09-03 | |||||
| 2026-04-24 | $123.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $826.00M derived: sum of 2 quarters · filed 2026-06-18 | $644.00M derived: sum of 3 quarters · filed 2026-06-18 | $46.00M 10-K · filed 2026-06-18 | |||||
| 2026-01-23 | $703.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-24 | $521.00M derived: sum of 2 quarters · filed 2026-02-24 | -$77.00M 10-Q · filed 2026-02-24 | $289.00M derived: sum of 4 quarters · filed 2026-09-03 | |||||
| 2025-10-24 | -$182.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-25 | -$780.00M 10-Q · filed 2025-11-25 | -$414.00M derived: sum of 3 quarters · filed 2026-09-03 | $136.00M derived: sum of 4 quarters · filed 2026-09-03 | |||||
| 2025-07-25 | -$598.00M 10-Q · filed 2026-09-03 | -$232.00M derived: sum of 2 quarters · filed 2026-09-03 | $318.00M derived: sum of 3 quarters · filed 2026-09-03 | $215.00M derived: sum of 4 quarters · filed 2026-09-03 | |||||
| 2025-04-25 | $366.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $916.00M derived: sum of 2 quarters · filed 2026-06-18 | $813.00M derived: sum of 3 quarters · filed 2026-06-18 | $209.00M 10-K · filed 2026-06-18 | |||||
| 2025-01-24 | $550.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-24 | $447.00M derived: sum of 2 quarters · filed 2026-02-24 | -$157.00M 10-Q · filed 2026-02-24 | $487.00M derived: sum of 4 quarters · filed 2026-06-18 | |||||
| 2024-10-25 | -$103.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-25 | -$707.00M 10-Q · filed 2025-11-25 | -$63.00M derived: sum of 3 quarters · filed 2026-06-18 | $383.00M derived: sum of 4 quarters · filed 2026-06-18 | |||||
| 2024-07-26 | -$604.00M 10-Q · filed 2025-08-26 | $40.00M derived: sum of 2 quarters · filed 2026-06-18 | $486.00M derived: sum of 3 quarters · filed 2026-06-18 | $460.00M derived: sum of 4 quarters · filed 2026-06-18 | |||||
| 2024-04-26 | $644.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $1.09B derived: sum of 2 quarters · filed 2026-06-18 | $1.06B derived: sum of 3 quarters · filed 2026-06-18 | $391.00M 10-K · filed 2026-06-18 | |||||
| 2024-01-26 | $446.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-25 | $420.00M derived: sum of 2 quarters · filed 2025-02-25 | -$253.00M 10-Q · filed 2025-02-25 | $280.00M derived: sum of 4 quarters · filed 2025-06-20 | |||||
| 2023-10-27 | -$26.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-26 | -$699.00M 10-Q · filed 2024-11-26 | -$166.00M derived: sum of 3 quarters · filed 2025-06-20 | $11.00M derived: sum of 4 quarters · filed 2025-06-20 | |||||
| 2023-07-28 | -$673.00M 10-Q · filed 2024-08-27 | -$140.00M derived: sum of 2 quarters · filed 2025-06-20 | $37.00M derived: sum of 3 quarters · filed 2025-06-20 | $170.00M derived: sum of 4 quarters · filed 2025-06-20 | |||||
| 2023-04-28 | $533.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $710.00M derived: sum of 2 quarters · filed 2025-06-20 | $843.00M derived: sum of 3 quarters · filed 2025-06-20 | $696.00M 10-K · filed 2025-06-20 | |||||
| 2023-01-27 | $177.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-27 | $310.00M derived: sum of 2 quarters · filed 2024-02-27 | $163.00M 10-Q · filed 2024-02-27 | $370.00M derived: sum of 4 quarters · filed 2024-06-20 | |||||
| 2022-10-28 | $133.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-30 | -$14.00M 10-Q · filed 2023-11-30 | $193.00M derived: sum of 3 quarters · filed 2024-06-20 | $645.00M derived: sum of 4 quarters · filed 2024-06-20 | |||||
| 2022-07-29 | -$147.00M 10-Q · filed 2023-08-31 | $60.00M derived: sum of 2 quarters · filed 2024-06-20 | $512.00M derived: sum of 3 quarters · filed 2024-06-20 | $482.00M derived: sum of 4 quarters · filed 2024-06-20 | |||||
| 2022-04-29 | $207.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-20 | $659.00M derived: sum of 2 quarters · filed 2024-06-20 | $629.00M derived: sum of 3 quarters · filed 2024-06-20 | $213.00M 10-K · filed 2024-06-20 | |||||
| 2022-01-28 | $452.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-01 | $422.00M derived: sum of 2 quarters · filed 2023-03-01 | $6.00M 10-Q · filed 2023-03-01 | $8.00M derived: sum of 4 quarters · filed 2023-06-22 | |||||
| 2021-10-29 | -$30.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-01 | -$446.00M 10-Q · filed 2022-12-01 | -$444.00M derived: sum of 3 quarters · filed 2023-06-22 | -$23.00M derived: sum of 4 quarters · filed 2023-06-22 | |||||
| 2021-07-30 | -$416.00M 10-Q · filed 2022-09-01 | -$414.00M derived: sum of 2 quarters · filed 2023-06-22 | $7.00M derived: sum of 3 quarters · filed 2023-06-22 | $656.00M derived: sum of 4 quarters · filed 2023-06-22 | |||||
| 2021-04-30 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | $423.00M derived: sum of 2 quarters · filed 2023-06-22 | $1.07B derived: sum of 3 quarters · filed 2023-06-22 | $531.00M 10-K · filed 2023-06-22 | |||||
| 2021-01-29 | $421.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-03 | $1.07B derived: sum of 2 quarters · filed 2022-03-03 | $529.00M 10-Q · filed 2022-03-03 | $382.00M derived: sum of 4 quarters · filed 2022-06-23 | |||||
| 2020-10-30 | $649.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-02 | $108.00M 10-Q · filed 2021-12-02 | -$39.00M derived: sum of 3 quarters · filed 2022-06-23 | $358.00M derived: sum of 4 quarters · filed 2022-06-23 | |||||
| 2020-07-31 | -$541.00M 10-Q · filed 2021-09-02 | -$688.00M derived: sum of 2 quarters · filed 2022-06-23 | -$291.00M derived: sum of 3 quarters · filed 2022-06-23 | $44.00M derived: sum of 4 quarters · filed 2022-06-23 | |||||
| 2020-04-24 | -$147.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | $250.00M derived: sum of 2 quarters · filed 2022-06-23 | $585.00M derived: sum of 3 quarters · filed 2022-06-23 | -$44.00M 10-K · filed 2022-06-23 | |||||
| 2020-01-24 | $397.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-05 | $732.00M derived: sum of 2 quarters · filed 2021-03-05 | $103.00M 10-Q · filed 2021-03-05 | $291.00M derived: sum of 4 quarters · filed 2021-06-25 | |||||
| 2019-10-25 | $335.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-03 | -$294.00M 10-Q · filed 2020-12-03 | -$106.00M derived: sum of 3 quarters · filed 2021-06-25 | $81.00M derived: sum of 4 quarters · filed 2021-06-25 | |||||
| 2019-07-26 | -$629.00M 10-Q · filed 2020-09-03 | -$441.00M derived: sum of 2 quarters · filed 2021-06-25 | -$254.00M derived: sum of 3 quarters · filed 2021-06-25 | -$315.00M derived: sum of 4 quarters · filed 2021-06-25 | |||||
| 2019-04-26 | $188.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-25 | $375.00M derived: sum of 2 quarters · filed 2021-06-25 | $314.00M derived: sum of 3 quarters · filed 2021-06-25 | $399.00M 10-K · filed 2021-06-25 | |||||
| 2019-01-25 | $187.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-28 | $126.00M derived: sum of 2 quarters · filed 2020-02-28 | $211.00M 10-Q · filed 2020-02-28 | $263.00M derived: sum of 4 quarters · filed 2020-06-19 | |||||
| 2018-10-26 | -$61.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-03 | $24.00M 10-Q · filed 2019-12-03 | $76.00M derived: sum of 3 quarters · filed 2020-06-19 | $396.00M derived: sum of 4 quarters · filed 2020-06-19 | |||||
| 2018-07-27 | $85.00M 10-Q · filed 2019-08-30 | $137.00M derived: sum of 2 quarters · filed 2020-06-19 | $457.00M derived: sum of 3 quarters · filed 2020-06-19 | $542.00M derived: sum of 4 quarters · filed 2020-06-19 | |||||
| 2018-04-27 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-19 | $372.00M derived: sum of 2 quarters · filed 2020-06-19 | $457.00M derived: sum of 3 quarters · filed 2020-06-19 | $65.00M 10-K · filed 2020-06-19 | |||||
| 2018-01-26 | $320.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-01 | $405.00M derived: sum of 2 quarters · filed 2019-03-01 | $13.00M 10-Q · filed 2019-03-01 | $337.00M derived: sum of 4 quarters · filed 2019-06-21 | |||||
| 2017-10-27 | $85.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-29 | -$307.00M 10-Q · filed 2018-11-29 | $17.00M derived: sum of 3 quarters · filed 2019-06-21 | $355.00M derived: sum of 4 quarters · filed 2019-06-21 | |||||
| 2017-07-28 | -$392.00M 10-Q · filed 2018-08-31 | -$68.00M derived: sum of 2 quarters · filed 2019-06-21 | $270.00M derived: sum of 3 quarters · filed 2019-06-21 | $262.00M derived: sum of 4 quarters · filed 2019-06-21 | |||||
| 2017-04-28 | $324.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-21 | $662.00M derived: sum of 2 quarters · filed 2019-06-21 | $654.00M derived: sum of 3 quarters · filed 2019-06-21 | $356.00M 10-K · filed 2019-06-21 | |||||
| 2017-01-27 | $338.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-02 | $330.00M derived: sum of 2 quarters · filed 2018-03-02 | $32.00M 10-Q · filed 2018-03-02 | -$124.00M 10-Q · filed 2017-03-03 | -$524.00M derived: sum of 4 quarters · filed 2018-06-22 | ||||
| 2016-10-28 | -$8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-04 | -$306.00M 10-Q · filed 2017-12-04 | -$271.00M 10-Q · filed 2016-12-05 | -$862.00M derived: sum of 3 quarters · filed 2018-06-22 | -$316.00M derived: sum of 4 quarters · filed 2018-06-22 | ||||
| 2016-07-29 | -$298.00M 10-Q · filed 2017-09-01 | -$361.00M 10-Q · filed 2016-09-07 | -$854.00M derived: sum of 2 quarters · filed 2018-06-22 | -$308.00M derived: sum of 3 quarters · filed 2018-06-22 | -$253.00M derived: sum of 4 quarters · filed 2018-06-22 | ||||
| 2016-04-29 | -$556.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-22 | -$10.00M derived: sum of 2 quarters · filed 2018-06-22 | $45.00M derived: sum of 3 quarters · filed 2018-06-22 | -$379.00M 10-K · filed 2018-06-22 | -$65.00M 10-K · filed 2016-06-28 | ||||
| 2016-01-29 | $546.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-03 | $601.00M derived: sum of 2 quarters · filed 2017-03-03 | $177.00M 10-Q · filed 2017-03-03 | $324.00M derived: sum of 4 quarters · filed 2017-06-27 | |||||
| 2015-10-30 | $55.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-05 | -$369.00M 10-Q · filed 2016-12-05 | -$222.00M derived: sum of 3 quarters · filed 2017-06-27 | $454.00M derived: sum of 4 quarters · filed 2017-06-27 | |||||
| 2015-07-31 | -$424.00M 10-Q · filed 2016-09-07 | -$277.00M derived: sum of 2 quarters · filed 2017-06-27 | $399.00M derived: sum of 3 quarters · filed 2017-06-27 | $588.00M derived: sum of 4 quarters · filed 2017-06-27 | |||||
| 2015-04-24 | $147.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-27 | $823.00M derived: sum of 2 quarters · filed 2017-06-27 | $1.01B derived: sum of 3 quarters · filed 2017-06-27 | $849.00M 10-K · filed 2017-06-27 | $1.62B 10-K · filed 2015-06-23 | ||||
| 2015-01-23 | $676.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-09 | $865.00M derived: sum of 2 quarters · filed 2016-03-09 | $37.00M 10-Q · filed 2015-02-27 | $702.00M 10-Q · filed 2016-03-09 | |||||
| 2014-10-24 | $189.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-09 | $26.00M 10-Q · filed 2015-12-09 | |||||||
| 2014-07-25 | -$163.00M 10-Q · filed 2015-09-09 | ||||||||
| 2014-04-25 | -$117.00M 10-K · filed 2016-06-28 | ||||||||
| 2013-04-26 | $481.00M 10-K · filed 2015-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |